The influence of renal manifestations to the progression of XXXX .

@entity1 @entity8 @entity3835 @entity177 @entity1290 @entity1790 @entity1011 @entity811 @entity293
BACKGROUND: @entity1290 , @entity293 ( @entity293 ) and gross @entity811 (GH) are the most important renal manifestations of @entity8 ( @entity8 ). They are not only common, but are also frequent cause of morbidity, influencing @entity8 . The aim of this study was to evaluate the frequency of these manifestations in our @entity1 with @entity8 and their impact on renal function. METHODS: One hundred eighty @entity8 @entity1 were included in the study. Subjects were studied for the presence of @entity293 , gross @entity811 frequency and responsible factors of @entity1790 . Survival times were calculated as the time to renal replacement therapy or time of serum @entity1011 value up to 10 mg/dl. Kaplan-Meier product-limit survival curves were constructed, and log rank test was used to compare the survival curves. RESULTS: @entity1290 were present in 76/180 (42% of pts). The stones were composed of urate (47%) @entity3835 (39%), and other compounds 14%. @entity293 was observed in 60% (108 @entity1 ). @entity1 treated with urinary disinfectants had a significant lower frequency of @entity293 (p<0.001) and @entity811 (p<0.001) after one year than untreated @entity1 . Gross @entity811 was present in 113 @entity1 (63%). In 43 @entity1 @entity811 was diagnosed before age 30 (38%), while in 70 @entity1 it was diagnosed after age 30 (62%). CONCLUSIONS: @entity293 is frequent in our @entity8 @entity1 . The correct treatment of @entity293 decreases its frequency and has beneficial role in the rate of progression to @entity177 in @entity8 @entity1 . @entity1 with recurrent episodes of gross @entity811 may be at risk for more severe @entity8 .
